Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 3 , Pages 235-236 , May 2010

Acute transient phlebitis during eptifibatide intravenous injection: Case report

  • Emile Hay, MD

      Affiliations

    • Quality Control and Risk Management Unit
    • ,
  • Yossef Blaer, RN, MSc

      Affiliations

    • Department of Cardiology, Barzilai Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
    • Corresponding Author InformationCorresponding author: Yossef Blaer, RN, MSc, Barzilai Medical Center, Hahistadrout St. 2, Ashkelon 78278, Israel.
    • ,
  • Vladimir Shlyakhover, MD

      Affiliations

    • Department of Cardiology, Barzilai Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
    • ,
  • Amos Katz, MD

      Affiliations

    • Department of Cardiology, Barzilai Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel
    • ,
  • Jamal Jafari, MD

      Affiliations

    • Department of Cardiology, Barzilai Medical Center, Ben-Gurion University of the Negev, Ashkelon, Israel

References 

  1. Harrington RA, Becker RC, Cannon CP, Gutterman D, Lincoff AM, Popma JJ, et al. American College of Chest Physicians. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(Suppl 6):670S–707S
  2. Zeymer U, Wienbergen H. A review of clinical trials with eptifibatide in cardiology. Cardiovasc Drug Rev. 2007;25:301–315
  3. Topol EJ, Byzova TV, Plow EF. Platelet GPIIb-IIIa blockers. Lancet. 1999;353:227–231
  4. Topol EJ, Moliterno DJ, Herrmann HC, Powers ER, Grines CL, Cohen DJ, et al. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. N Engl J Med. 2001;344:1888–1894
  5. In:  Lacy CF,  Armstrong LL,  Goldman MP,  Lance LL editor. Drug information handbook with international trade index. Ashkelon: American Pharmacists Association. 17th ed. Lexi-Comp, Inc; 2008;p. 563–564
  6. Cannon CH, Battler AL, Brindis RA, Cox JA, Ellist ST, Every NA, et al. ACC clinical data standards. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. J Am Coll Cardiol. 2001;38:2114–2130
  7. Frey AM. Success rate for peripheral IV insertion in a children's hospital. J Intraven Nurs. 1998;21:160–165
  8. Kokotis K. Preventing chemical phlebitis. Nursing. 1998;28:41–46
  9. Zhao L, Yalkowsky SH. Stabilization of eptifibatide by co-solvents. Int J Pharm. 2001;218:43–56

PII: S0147-9563(09)00181-2

doi: 10.1016/j.hrtlng.2009.07.003

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 3 , Pages 235-236 , May 2010

Article Tools